Series A

Subtle Medical sucks in series A funds
Baidu-backed Subtle Medical produces AI-driven medical imaging software intended to work across different healthcare systems, and has raised $12.2m.
Catamaran Bio catalyses $42m
Takeda Ventures and Astellas Venture Management both backed cell therapy developer Catamaran as it emerged from stealth.
Resilience reveals $800m at launch
GV is among the investors in the pharmaceutical manufacturing technology startup, which recently secured $750m in series B funding.
GV steers Headway to $26m series A
The Alphabet investment vehicle has helped the online therapist network close a series A round that increased its total funding to $32m.
Corporate venturing deal net: 16-20 November 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
D3 Bio deals in $200m
WuXi AppTec’s Corporate Venture Fund was among the participants in a series A round disclosed as the precision medicine startup emerged from stealth.
Springtide sparks series A surge
The child developmental therapy provider closed an $18.1m round co-led by Optum Ventures, which will take a board seat at the company.
Metagenomi sets out $65m series A
Gene editing technology developer Metagenomi closed its first round since emerging from stealth, with Leaps by Bayer the co-lead.

Other News

Curbio curates $25m round
The home improvement services provider increased its overall funding to more than $38m in a round led by Comcast Ventures.
Analysis: IQM computes a $46m round
IQM Quantum Computers has raised a series A round that included Tencent, among other investors. The technology is still in its infancy and our data suggest that few corporates have so far backed such enterprises but this may change in the future.
Corporate venturing deal net: 9-13 November 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Kira comes out of stealth with $46m
Sinopharm Capital and the WuXi AppTec-backed 6 Dimensions Capital are among the investors in the inflammatory and autoimmune disease drug developer.
Inipharm harvests $35m in series A round
The round included Jubilant Biosys, an existing investor in the liver disease drug startup as well as its contract research organisation partner.
Isovalent isolates $29m in series A round
Cisco Investments and Google have both made early-stage bets on Isovalent, a developer of cloud networking management and security tools.

Editor's Picks

Intel spreads $72m across 12 companies
Intel Capital has revealed investments in 12 US or China-based portfolio companies and a partnership with the NBA.
Intel Capital reaches Horizon in $60m data spree
The unit is set to lead a $100m round for Horizon Robotics as part of $60m investment in data-focused companies, taking its total 2017 spending to almost $570m.
Intel Capital funds three more in Israel
The corporate venturing unit invested $25m to lead early-stage rounds for Velostrata, Sedona Systems and Panoply.io totalling $38.5m.
News round up 11 May 2015
A round up of all the latest news on www.globalcorporateventuring.com for our subscribers.
test reg

Login